Novo Nordisk global sales were driven by diabetes and obesity care sales.
You are here: Home / Top Stories / Dow Jones Newswires: Novo Nordisk lifts dividend, launches $4.09 billion share buyback after earnings beat forecasts
Market News and Views
Novo Nordisk global sales were driven by diabetes and obesity care sales.